METHOD FOR PREDICTION OF RISK OF ADVERSE CARDIOVASCULAR EVENTS WITHIN 12 MONTHS AFTER CORONARY BYPASS SURGERY
2024-04-04
专利权人AS RUSSIA TOMSK NAT RES MEDICAL CENT (ASTO-Non-standard)
申请日期2024-04-04
专利号RU2830502-C1
成果简介NOVELTY - Invention relates to medicine, namely to cardiology, and can be used to predict the risk of adverse cardiovascular events within 12 months after coronary bypass surgery. Blood serum of the patients with ischemic heart disease scheduled for coronary artery bypass surgery is examined for the concentration of growth/differentiation factor 15 (GDF-15), pg/ml, and the ratio of neutrophils to blood lymphocytes (NEUT/LYMPH). Risk of adverse cardiovascular events is calculated by formula: p = GDF-15 × (NEUT/LYMPH), where p is the probability of adverse cardiovascular events within 12 months after coronary bypass surgery. If the p value is 3,216 and more, a high risk of unfavourable cardiovascular events is predicted. USE - Medicine. ADVANTAGE - Method enables predicting the risk of adverse cardiovascular events for 12 months after coronary artery bypass grafting by measuring blood serum of patients with coronary artery disease planned for coronary artery bypass grafting, concentration of GDF-15 and ratio of neutrophils to blood lymphocytes. 1 cl, 2 tbl, 3 ex
IPC 分类号G01N-033/49 ; G01N-033/68
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/17385
专题中国科学院新疆生态与地理研究所
作者单位
AS RUSSIA TOMSK NAT RES MEDICAL CENT (ASTO-Non-standard)
推荐引用方式
GB/T 7714
GARGANEEVA A A,KUZHELEVA E A,TUKISH O V,et al. METHOD FOR PREDICTION OF RISK OF ADVERSE CARDIOVASCULAR EVENTS WITHIN 12 MONTHS AFTER CORONARY BYPASS SURGERY. RU2830502-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。